Arbutus Biopharma
ABUS
#7051
Rank
NZ$1.12 B
Marketcap
NZ$7.35
Share price
-1.23%
Change (1 day)
-4.26%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2026 (TTM): NZ$1.42

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is NZ$1.50. In 2025 the company made an earnings per share (EPS) of NZ-$0.31 an increase over its 2024 EPS that were of NZ-$0.69.

EPS history for Arbutus Biopharma from 1998 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.42-558.02%
2025NZ-$0.31-55.26%
2024NZ-$0.69-13.64%
2023NZ-$0.80-4.35%
2022NZ-$0.84-44.58%
2021NZ-$1.52-17%
2020NZ-$1.83-65.4%
2019NZ-$5.28138.84%
2018NZ-$2.21-22.44%
2017NZ-$2.85-78.45%
2016NZ-$13.23424.64%
2015NZ-$2.52-20.19%
2014NZ-$3.1687.96%
2013NZ-$1.68-142.59%
2012NZ$3.95-342.7%
2011NZ-$1.63-25.82%
2010NZ-$2.1947.8%
2009NZ-$1.48-43.55%
2008NZ-$2.63158.91%
2007NZ-$1.02-111.88%
2006NZ$8.55-552.53%
2005NZ-$1.89-71.77%
2004NZ-$6.69-14.48%
2003NZ-$7.82-8.95%
2002NZ-$8.5970.07%
2001NZ-$5.0548.01%
2000NZ-$3.41-38.54%
1999NZ-$5.55-24.6%
1998NZ-$7.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
NZ-$0.11-107.32% Bahamas
NRC Health
NRC
NZ$0.53-64.63%๐Ÿ‡บ๐Ÿ‡ธ USA